Xiang Yan-Qun, Min Hua-Qing, Hong Ming-Huang, Cao Su-Mei, He Jie-Hua, Hou Jing-Hui, Guo Xiang
Department of Nasopharyngeal Carcinoma, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, PR China.
Ai Zheng. 2004 Mar;23(3):322-5.
BACKGROUND & OBJECTIVE: TopoisomeraseIIalpha (TopoIIalpha) is a protein in eukaryotic cell with many different roles in DNA duplication and repair. It was reported that the expression level of TopoIIalpha was related to the prognosis of many malignant tumors. The aim of this study was to investigate the relationship of expression of TopoIIalpha in nasopharyngeal carcinoma (NPC) with clinicopathologic factors and its prognostic significance.
The expression of TopoIIalpha was observed in 114 NPC cases using immunohistochemical staining. All of the patients were divided into two groups according to the expression level of TopoIIalpha. Kaplan-Meier survival analysis was used to analyze the relationship of expression of TopoIIalpha with recurrence and metastasis of tumor after radiotherapy. Cox proportional hazards model analysis was used to analyze the factors related to local recurrence of tumor.
The expression of TopoIIalpha in NPC cells ranged from 0 to 90%; the average percentage was (22.63+/-21.92)%. The positive rate of TopoIIalpha was 43.9% (50/114) when 20% was used as the cut-off point. The positive rate of TopoIIalpha was not related to the sex, age, pathological type, and clinical staging. The 3-year relapse-free survival rates of negative group and positive group were 93.1% and 74.3%, respectively (P=0.0027). The 3-year disease-free survival rates of the two groups were 77.9% and 58.9%, respectively (P=0.0091). The metastasis-free survival rates of the two groups were 81.1% and 77.6%, respectively (P=0.566). Cox proportional hazards model analysis showed that the local recurrence of tumor was independently affected by the expression of TopoIIalpha.
There is a high expression level of TopoIIalpha in a part of NPC.NPC patients with high expression of TopoIIalpha have a higher local recurrence rate and worse prognosis.
拓扑异构酶IIα(TopoIIα)是真核细胞中的一种蛋白质,在DNA复制和修复中发挥多种不同作用。据报道,TopoIIα的表达水平与多种恶性肿瘤的预后相关。本研究旨在探讨鼻咽癌(NPC)中TopoIIα的表达与临床病理因素的关系及其预后意义。
采用免疫组织化学染色观察114例NPC病例中TopoIIα的表达。所有患者根据TopoIIα的表达水平分为两组。采用Kaplan-Meier生存分析来分析TopoIIα的表达与放疗后肿瘤复发和转移的关系。采用Cox比例风险模型分析与肿瘤局部复发相关的因素。
NPC细胞中TopoIIα的表达范围为0至90%;平均百分比为(22.63±21.92)%。以20%为截断点时,TopoIIα的阳性率为43.9%(50/114)。TopoIIα的阳性率与性别、年龄、病理类型和临床分期无关。阴性组和阳性组的3年无复发生存率分别为93.1%和74.3%(P = 0.0027)。两组的3年无病生存率分别为77.9%和58.9%(P = 0.0091)。两组的无转移生存率分别为81.1%和77.6%(P = 0.566)。Cox比例风险模型分析表明,肿瘤的局部复发独立受TopoIIα表达的影响。
部分NPC中存在TopoIIα高表达。TopoIIα高表达的NPC患者局部复发率较高,预后较差。